Dr. Neparidze is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
# WWW403
New Haven, CT 06510Phone+1 203-785-4144Fax+1 203-785-7232
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010- Yale-New Haven Medical CenterResidency, Internal Medicine, 2004 - 2007
"Aieti" Highest Medical SchoolClass of 2000
Certifications & Licensure
CT State Medical License 2010 - 2025- CT State Medical License 2008 - 2024
NY State Medical License 2010 - 2015- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma Start of enrollment: 2022 Feb 21
- Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma Start of enrollment: 2024 Nov 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 2 citationsRefractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case report.Lake R Crawford, Natalia Neparidze
Clinical Case Reports. 2022-03-01 - 10 citationsImpact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States.Ravi B Parikh, Samuel U Takvorian, Daniel Vader, E Paul Wileyto, Amy S Clark
Journal of the National Cancer Institute. 2022-04-11 - 60 citationsA highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies.Yuanbin Song, Anthony Rongvaux, Ashley Taylor, Tingting Jiang, Toma Tebaldi
Nature Communications. 2019-01-21
Abstracts/Posters
- Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center ExperienceNatalia Neparidze, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United State...Natalia Neparidze, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Trial in Progress: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in ...Natalia Neparidze, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
